Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1061 clinical trials
Adenovirus Keratoconjunctivitis and Ophtalmology

Adenovirus conjunctivitis is an epidemic disease registered as a common occupational disease for ophthalmologists and orthoptists. It can leave corneal sequelae even several years after infection.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Clinical and Genetic Analysis of ROP

The investigators feel that this study will result in specific knowledge discovery about ROP, as well as general knowledge about how image-based data and genetic data can be combined to better understand clinical disease. Participants will be recruited from the neonatal intensive care unit (NICU) at OHSU, along with 4 …

vascular disease
strabismus
genetic analysis
retinopathy
pediatric
  • 0 views
  • 19 Feb, 2024
  • 5 locations
French COVID Cohort

Infectious disease is the single biggest cause of death worldwide. New infectious agents, such as the SARS, MERS and other novel coronavirus, novel influenza viruses, viruses causing viral haemorrhagic fever (e.g. Ebola), and viruses that affect the central nervous system (CNS) such as TBEV & Nipah require investigation to understand …

coronavirus infection
antibiotics
acute respiratory syndrome (sars)
fever
mers
  • 0 views
  • 19 Feb, 2024
  • 81 locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives of the Registry are: To enhance understanding of the variability, progression, identification, and natural history of Gaucher disease, with the ultimate goal of better guiding and …

gaucher disease
eliglustat
deficiency
imiglucerase
  • 0 views
  • 19 Feb, 2024
  • 221 locations
Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

Apatinib, also known as YN968D1, is a small-molecule tyrosine kinase inhibitor (TKI) that selectively binds to and inhibits vascular endothelial growth factor receptor 2 (VEGFR-2).

growth factor
vegf
postoperative complication
platelet count
liver metastasis
  • 0 views
  • 19 Feb, 2024
  • 1 location
AXillary Surgery After NeoAdjuvant Treatment

Therefore, the EUBREAST study group decided to initiate a prospective cohort study as an international project that aims at comparatively evaluating data on axillary staging after neoadjuvant therapy.

sentinel node
fine needle aspiration
core needle biopsy
lymphadenectomy
invasive breast cancer
  • 0 views
  • 19 Feb, 2024
  • 9 locations
Lyon Granulomatous Hepatitis Study

This study will permit a better characterization of granulomatous hepatitis, and liver sarcoidosis in terms of prognosis as well as therapeutic management.

  • 0 views
  • 19 Feb, 2024
  • 3 locations
Singapore COVID-19 Chemosensory Tracking (SCCT) Study

Using standardised questionnaire and testing approaches, the investigators aim to objectively characterise and measure temporal changes in taste and smell to confirm the prevalence of these symptoms as an early marker of infection. Information on symptoms experience, changes in appetite and food-related quality of life will be also be assessed …

anosmia
ageusia
  • 0 views
  • 19 Feb, 2024
  • 1 location
Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer

Cancer care structures quickly reorganized to limit high-risk situations (diagnostic procedure, major surgery, cytotoxic poly-chemotherapy) and use alternatives such as on-hold chemotherapy. These reorganizations could be associated with a loss of chance for pancreatic adenocarcinoma.

cancer
diagnostic procedure
adenocarcinoma
covid-19
major surgery
  • 0 views
  • 19 Feb, 2024
  • 1 location
LIPAD - LRRK2 International Parkinson's Disease Study

The comprehensive investigation of mechanisms of reduced penetrance but also of the effects of the mutation itself requires systematic investigations of as many affected persons as possible. We therefore aim to identify 4,000 people internationally, of them 1,500 with LRRK2-associated Parkinson's syndrome, 500 with LRRK2-mutations but without Parkinson's symptoms, 500 …

  • 0 views
  • 19 Feb, 2024
  • 1 location